nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—Blood calcium decreased—Varenicline—nicotine dependence	0.0351	0.0901	CcSEcCtD
Vandetanib—ORM1—saliva—nicotine dependence	0.0235	0.0619	CbGeAlD
Vandetanib—Transient ischaemic attack—Varenicline—nicotine dependence	0.0158	0.0405	CcSEcCtD
Vandetanib—Balance disorder—Varenicline—nicotine dependence	0.0146	0.0374	CcSEcCtD
Vandetanib—Platelet count decreased—Varenicline—nicotine dependence	0.0134	0.0344	CcSEcCtD
Vandetanib—Cyst—Varenicline—nicotine dependence	0.0119	0.0306	CcSEcCtD
Vandetanib—Fungal infection—Varenicline—nicotine dependence	0.0103	0.0265	CcSEcCtD
Vandetanib—Nephrolithiasis—Varenicline—nicotine dependence	0.00991	0.0254	CcSEcCtD
Vandetanib—FLT3—cardiovascular system—nicotine dependence	0.00978	0.0257	CbGeAlD
Vandetanib—Endocrine disorder—Varenicline—nicotine dependence	0.00961	0.0247	CcSEcCtD
Vandetanib—Acne—Varenicline—nicotine dependence	0.00947	0.0243	CcSEcCtD
Vandetanib—EPHA5—midbrain—nicotine dependence	0.00898	0.0236	CbGeAlD
Vandetanib—FLT4—cardiovascular system—nicotine dependence	0.00888	0.0234	CbGeAlD
Vandetanib—RIPK2—cardiovascular system—nicotine dependence	0.00883	0.0233	CbGeAlD
Vandetanib—MKNK1—cardiovascular system—nicotine dependence	0.00794	0.0209	CbGeAlD
Vandetanib—FGR—cardiovascular system—nicotine dependence	0.00784	0.0206	CbGeAlD
Vandetanib—AXL—cardiovascular system—nicotine dependence	0.00781	0.0206	CbGeAlD
Vandetanib—LTK—brain—nicotine dependence	0.00761	0.02	CbGeAlD
Vandetanib—STK35—midbrain—nicotine dependence	0.00748	0.0197	CbGeAlD
Vandetanib—Dry eye—Varenicline—nicotine dependence	0.00736	0.0189	CcSEcCtD
Vandetanib—FYN—cardiovascular system—nicotine dependence	0.00731	0.0192	CbGeAlD
Vandetanib—EPHA8—brain—nicotine dependence	0.00729	0.0192	CbGeAlD
Vandetanib—TEK—cardiovascular system—nicotine dependence	0.00714	0.0188	CbGeAlD
Vandetanib—RIPK2—midbrain—nicotine dependence	0.0069	0.0182	CbGeAlD
Vandetanib—ERBB3—midbrain—nicotine dependence	0.0066	0.0174	CbGeAlD
Vandetanib—STK10—cardiovascular system—nicotine dependence	0.00654	0.0172	CbGeAlD
Vandetanib—SRC—cardiovascular system—nicotine dependence	0.00635	0.0167	CbGeAlD
Vandetanib—MKNK1—midbrain—nicotine dependence	0.0062	0.0163	CbGeAlD
Vandetanib—RET—midbrain—nicotine dependence	0.00612	0.0161	CbGeAlD
Vandetanib—Atrial fibrillation—Varenicline—nicotine dependence	0.0061	0.0157	CcSEcCtD
Vandetanib—AXL—midbrain—nicotine dependence	0.0061	0.0161	CbGeAlD
Vandetanib—EPHA6—brain—nicotine dependence	0.00608	0.016	CbGeAlD
Vandetanib—PLK4—brain—nicotine dependence	0.00601	0.0158	CbGeAlD
Vandetanib—Hypoglycaemia—Varenicline—nicotine dependence	0.00593	0.0152	CcSEcCtD
Vandetanib—Lethargy—Varenicline—nicotine dependence	0.0059	0.0151	CcSEcCtD
Vandetanib—SLK—midbrain—nicotine dependence	0.00587	0.0155	CbGeAlD
Vandetanib—MAP2K5—cardiovascular system—nicotine dependence	0.00584	0.0154	CbGeAlD
Vandetanib—KDR—cardiovascular system—nicotine dependence	0.00584	0.0154	CbGeAlD
Vandetanib—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.00578	0.0148	CcSEcCtD
Vandetanib—FYN—midbrain—nicotine dependence	0.00571	0.015	CbGeAlD
Vandetanib—EPHA5—brain—nicotine dependence	0.00564	0.0149	CbGeAlD
Vandetanib—TYRO3—brain—nicotine dependence	0.00564	0.0149	CbGeAlD
Vandetanib—LYN—brain—nicotine dependence	0.00561	0.0148	CbGeAlD
Vandetanib—TEK—midbrain—nicotine dependence	0.00558	0.0147	CbGeAlD
Vandetanib—MAP4K5—midbrain—nicotine dependence	0.00558	0.0147	CbGeAlD
Vandetanib—BMPR1B—brain—nicotine dependence	0.00553	0.0146	CbGeAlD
Vandetanib—MAP3K19—brain—nicotine dependence	0.00553	0.0146	CbGeAlD
Vandetanib—EPHB6—midbrain—nicotine dependence	0.00533	0.014	CbGeAlD
Vandetanib—Dry skin—Varenicline—nicotine dependence	0.0053	0.0136	CcSEcCtD
Vandetanib—Hypokalaemia—Varenicline—nicotine dependence	0.00526	0.0135	CcSEcCtD
Vandetanib—Nasopharyngitis—Varenicline—nicotine dependence	0.00517	0.0133	CcSEcCtD
Vandetanib—YES1—midbrain—nicotine dependence	0.00515	0.0136	CbGeAlD
Vandetanib—Gastritis—Varenicline—nicotine dependence	0.00512	0.0131	CcSEcCtD
Vandetanib—PDGFRB—cardiovascular system—nicotine dependence	0.00505	0.0133	CbGeAlD
Vandetanib—Dysphagia—Varenicline—nicotine dependence	0.005	0.0128	CcSEcCtD
Vandetanib—Bronchitis—Varenicline—nicotine dependence	0.00481	0.0123	CcSEcCtD
Vandetanib—STK35—brain—nicotine dependence	0.0047	0.0124	CbGeAlD
Vandetanib—Pollakiuria—Varenicline—nicotine dependence	0.00462	0.0119	CcSEcCtD
Vandetanib—ABL2—brain—nicotine dependence	0.00458	0.0121	CbGeAlD
Vandetanib—Photosensitivity reaction—Varenicline—nicotine dependence	0.00456	0.0117	CcSEcCtD
Vandetanib—KDR—midbrain—nicotine dependence	0.00456	0.012	CbGeAlD
Vandetanib—MAP2K5—midbrain—nicotine dependence	0.00456	0.012	CbGeAlD
Vandetanib—Hyperglycaemia—Varenicline—nicotine dependence	0.00451	0.0116	CcSEcCtD
Vandetanib—ABL1—cardiovascular system—nicotine dependence	0.0045	0.0119	CbGeAlD
Vandetanib—EGFR—brain—nicotine dependence	0.00447	0.0118	CbGeAlD
Vandetanib—Infestation—Varenicline—nicotine dependence	0.00446	0.0114	CcSEcCtD
Vandetanib—Infestation NOS—Varenicline—nicotine dependence	0.00446	0.0114	CcSEcCtD
Vandetanib—Depression—Varenicline—nicotine dependence	0.00444	0.0114	CcSEcCtD
Vandetanib—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00442	0.0113	CcSEcCtD
Vandetanib—FLT4—brain—nicotine dependence	0.00436	0.0115	CbGeAlD
Vandetanib—Stomatitis—Varenicline—nicotine dependence	0.00434	0.0112	CcSEcCtD
Vandetanib—RIPK2—brain—nicotine dependence	0.00433	0.0114	CbGeAlD
Vandetanib—Conjunctivitis—Varenicline—nicotine dependence	0.00433	0.0111	CcSEcCtD
Vandetanib—VEGFA—brain—nicotine dependence	0.00432	0.0114	CbGeAlD
Vandetanib—FMO1—brain—nicotine dependence	0.0043	0.0113	CbGeAlD
Vandetanib—IRAK4—brain—nicotine dependence	0.00423	0.0111	CbGeAlD
Vandetanib—Hepatobiliary disease—Varenicline—nicotine dependence	0.00422	0.0108	CcSEcCtD
Vandetanib—Epistaxis—Varenicline—nicotine dependence	0.0042	0.0108	CcSEcCtD
Vandetanib—Sinusitis—Varenicline—nicotine dependence	0.00418	0.0107	CcSEcCtD
Vandetanib—ERBB3—brain—nicotine dependence	0.00415	0.0109	CbGeAlD
Vandetanib—Bradycardia—Varenicline—nicotine dependence	0.00407	0.0105	CcSEcCtD
Vandetanib—Urinary tract disorder—Varenicline—nicotine dependence	0.00395	0.0101	CcSEcCtD
Vandetanib—PDGFRB—midbrain—nicotine dependence	0.00395	0.0104	CbGeAlD
Vandetanib—Urethral disorder—Varenicline—nicotine dependence	0.00392	0.0101	CcSEcCtD
Vandetanib—MKNK1—brain—nicotine dependence	0.00389	0.0103	CbGeAlD
Vandetanib—Visual impairment—Varenicline—nicotine dependence	0.00386	0.0099	CcSEcCtD
Vandetanib—FGR—brain—nicotine dependence	0.00385	0.0101	CbGeAlD
Vandetanib—RET—brain—nicotine dependence	0.00385	0.0101	CbGeAlD
Vandetanib—AXL—brain—nicotine dependence	0.00383	0.0101	CbGeAlD
Vandetanib—Erythema multiforme—Varenicline—nicotine dependence	0.00378	0.00971	CcSEcCtD
Vandetanib—Eye disorder—Varenicline—nicotine dependence	0.00374	0.0096	CcSEcCtD
Vandetanib—FMO3—brain—nicotine dependence	0.00372	0.00978	CbGeAlD
Vandetanib—Cardiac disorder—Varenicline—nicotine dependence	0.00371	0.00953	CcSEcCtD
Vandetanib—SLK—brain—nicotine dependence	0.00369	0.00971	CbGeAlD
Vandetanib—Angiopathy—Varenicline—nicotine dependence	0.00363	0.00932	CcSEcCtD
Vandetanib—Mediastinal disorder—Varenicline—nicotine dependence	0.00361	0.00926	CcSEcCtD
Vandetanib—FYN—brain—nicotine dependence	0.00359	0.00944	CbGeAlD
Vandetanib—Arrhythmia—Varenicline—nicotine dependence	0.00357	0.00917	CcSEcCtD
Vandetanib—ABL1—midbrain—nicotine dependence	0.00352	0.00926	CbGeAlD
Vandetanib—Mental disorder—Varenicline—nicotine dependence	0.00351	0.009	CcSEcCtD
Vandetanib—MAP4K5—brain—nicotine dependence	0.0035	0.00923	CbGeAlD
Vandetanib—TEK—brain—nicotine dependence	0.0035	0.00923	CbGeAlD
Vandetanib—Malnutrition—Varenicline—nicotine dependence	0.00348	0.00894	CcSEcCtD
Vandetanib—Dysgeusia—Varenicline—nicotine dependence	0.00341	0.00875	CcSEcCtD
Vandetanib—EPHB6—brain—nicotine dependence	0.00335	0.00882	CbGeAlD
Vandetanib—Muscle spasms—Varenicline—nicotine dependence	0.00335	0.0086	CcSEcCtD
Vandetanib—Vision blurred—Varenicline—nicotine dependence	0.00328	0.00843	CcSEcCtD
Vandetanib—Tremor—Varenicline—nicotine dependence	0.00326	0.00838	CcSEcCtD
Vandetanib—YES1—brain—nicotine dependence	0.00324	0.00852	CbGeAlD
Vandetanib—STK10—brain—nicotine dependence	0.00321	0.00844	CbGeAlD
Vandetanib—SRC—brain—nicotine dependence	0.00311	0.0082	CbGeAlD
Vandetanib—Loss of consciousness—Varenicline—nicotine dependence	0.00306	0.00786	CcSEcCtD
Vandetanib—Cough—Varenicline—nicotine dependence	0.00304	0.0078	CcSEcCtD
Vandetanib—Convulsion—Varenicline—nicotine dependence	0.00302	0.00775	CcSEcCtD
Vandetanib—Hypertension—Varenicline—nicotine dependence	0.00301	0.00772	CcSEcCtD
Vandetanib—Arthralgia—Varenicline—nicotine dependence	0.00297	0.00761	CcSEcCtD
Vandetanib—Chest pain—Varenicline—nicotine dependence	0.00297	0.00761	CcSEcCtD
Vandetanib—Anxiety—Varenicline—nicotine dependence	0.00296	0.00758	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00295	0.00756	CcSEcCtD
Vandetanib—Dry mouth—Varenicline—nicotine dependence	0.0029	0.00744	CcSEcCtD
Vandetanib—KDR—brain—nicotine dependence	0.00286	0.00754	CbGeAlD
Vandetanib—MAP2K5—brain—nicotine dependence	0.00286	0.00754	CbGeAlD
Vandetanib—Oedema—Varenicline—nicotine dependence	0.00284	0.0073	CcSEcCtD
Vandetanib—Infection—Varenicline—nicotine dependence	0.00282	0.00725	CcSEcCtD
Vandetanib—Nervous system disorder—Varenicline—nicotine dependence	0.00279	0.00716	CcSEcCtD
Vandetanib—Thrombocytopenia—Varenicline—nicotine dependence	0.00278	0.00714	CcSEcCtD
Vandetanib—Skin disorder—Varenicline—nicotine dependence	0.00276	0.00709	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00259	0.00665	CcSEcCtD
Vandetanib—Insomnia—Varenicline—nicotine dependence	0.00257	0.0066	CcSEcCtD
Vandetanib—Dyspnoea—Varenicline—nicotine dependence	0.00253	0.0065	CcSEcCtD
Vandetanib—Dyspepsia—Varenicline—nicotine dependence	0.0025	0.00642	CcSEcCtD
Vandetanib—PDGFRB—brain—nicotine dependence	0.00248	0.00653	CbGeAlD
Vandetanib—Decreased appetite—Varenicline—nicotine dependence	0.00247	0.00634	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00245	0.0063	CcSEcCtD
Vandetanib—Fatigue—Varenicline—nicotine dependence	0.00245	0.00629	CcSEcCtD
Vandetanib—Pain—Varenicline—nicotine dependence	0.00243	0.00624	CcSEcCtD
Vandetanib—Constipation—Varenicline—nicotine dependence	0.00243	0.00624	CcSEcCtD
Vandetanib—Gastrointestinal pain—Varenicline—nicotine dependence	0.00232	0.00597	CcSEcCtD
Vandetanib—ABL1—Regulation of actin dynamics for phagocytic cup formation—WASF2—nicotine dependence	0.00228	0.00991	CbGpPWpGaD
Vandetanib—RET—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00227	0.00986	CbGpPWpGaD
Vandetanib—Body temperature increased—Varenicline—nicotine dependence	0.00225	0.00577	CcSEcCtD
Vandetanib—Abdominal pain—Varenicline—nicotine dependence	0.00225	0.00577	CcSEcCtD
Vandetanib—MAP2K5—ErbB1 downstream signaling—WASF2—nicotine dependence	0.00223	0.00968	CbGpPWpGaD
Vandetanib—YES1—Fcgamma receptor (FCGR) dependent phagocytosis—WASF1—nicotine dependence	0.00223	0.00966	CbGpPWpGaD
Vandetanib—ABCG2—midbrain—nicotine dependence	0.00222	0.00584	CbGeAlD
Vandetanib—ABL1—brain—nicotine dependence	0.00221	0.00582	CbGeAlD
Vandetanib—ABL1—Regulation of actin dynamics for phagocytic cup formation—WASF1—nicotine dependence	0.00219	0.0095	CbGpPWpGaD
Vandetanib—KDR—VEGFA-VEGFR2 Pathway—WASF2—nicotine dependence	0.00214	0.00929	CbGpPWpGaD
Vandetanib—KDR—VEGFA-VEGFR2 Pathway—WASF1—nicotine dependence	0.00205	0.00891	CbGpPWpGaD
Vandetanib—BLK—PDGFR-beta signaling pathway—WASF2—nicotine dependence	0.00204	0.00885	CbGpPWpGaD
Vandetanib—Asthenia—Varenicline—nicotine dependence	0.00204	0.00523	CcSEcCtD
Vandetanib—ALB—brain—nicotine dependence	0.00204	0.00537	CbGeAlD
Vandetanib—FGR—PDGFR-beta signaling pathway—WASF2—nicotine dependence	0.00203	0.00882	CbGpPWpGaD
Vandetanib—KDR—Signaling by VEGF—WASF2—nicotine dependence	0.00202	0.00877	CbGpPWpGaD
Vandetanib—Pruritus—Varenicline—nicotine dependence	0.00201	0.00516	CcSEcCtD
Vandetanib—Diarrhoea—Varenicline—nicotine dependence	0.00195	0.00499	CcSEcCtD
Vandetanib—KDR—Signaling by VEGF—WASF1—nicotine dependence	0.00194	0.00841	CbGpPWpGaD
Vandetanib—VEGFA—VEGFA-VEGFR2 Pathway—WASF2—nicotine dependence	0.00193	0.00835	CbGpPWpGaD
Vandetanib—Dizziness—Varenicline—nicotine dependence	0.00188	0.00482	CcSEcCtD
Vandetanib—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00185	0.00803	CbGpPWpGaD
Vandetanib—VEGFA—VEGFA-VEGFR2 Pathway—WASF1—nicotine dependence	0.00185	0.00801	CbGpPWpGaD
Vandetanib—VEGFA—Signaling by VEGF—WASF2—nicotine dependence	0.00182	0.00788	CbGpPWpGaD
Vandetanib—Vomiting—Varenicline—nicotine dependence	0.00181	0.00464	CcSEcCtD
Vandetanib—VEGFA—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.0018	0.00781	CbGpPWpGaD
Vandetanib—Rash—Varenicline—nicotine dependence	0.00179	0.0046	CcSEcCtD
Vandetanib—Dermatitis—Varenicline—nicotine dependence	0.00179	0.0046	CcSEcCtD
Vandetanib—Headache—Varenicline—nicotine dependence	0.00178	0.00457	CcSEcCtD
Vandetanib—RIPK2—Signaling by NGF—FGD1—nicotine dependence	0.00176	0.00763	CbGpPWpGaD
Vandetanib—PDGFRB—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00175	0.00757	CbGpPWpGaD
Vandetanib—VEGFA—Signaling by VEGF—WASF1—nicotine dependence	0.00174	0.00756	CbGpPWpGaD
Vandetanib—LYN—Fcgamma receptor (FCGR) dependent phagocytosis—WASF2—nicotine dependence	0.00173	0.00751	CbGpPWpGaD
Vandetanib—ABL1—Fcgamma receptor (FCGR) dependent phagocytosis—WASF2—nicotine dependence	0.00172	0.00748	CbGpPWpGaD
Vandetanib—FYN—Fcgamma receptor (FCGR) dependent phagocytosis—WASF2—nicotine dependence	0.00171	0.0074	CbGpPWpGaD
Vandetanib—Nausea—Varenicline—nicotine dependence	0.00169	0.00433	CcSEcCtD
Vandetanib—FMO3—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00168	0.0073	CbGpPWpGaD
Vandetanib—ABCC1—brain—nicotine dependence	0.00168	0.00443	CbGeAlD
Vandetanib—LYN—Fcgamma receptor (FCGR) dependent phagocytosis—WASF1—nicotine dependence	0.00166	0.0072	CbGpPWpGaD
Vandetanib—ABL1—Fcgamma receptor (FCGR) dependent phagocytosis—WASF1—nicotine dependence	0.00165	0.00717	CbGpPWpGaD
Vandetanib—YES1—PDGFR-beta signaling pathway—WASF2—nicotine dependence	0.00164	0.00712	CbGpPWpGaD
Vandetanib—FYN—Fcgamma receptor (FCGR) dependent phagocytosis—WASF1—nicotine dependence	0.00164	0.00709	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling by NGF—FGD1—nicotine dependence	0.00161	0.00698	CbGpPWpGaD
Vandetanib—ERBB3—Signaling by NGF—FGD1—nicotine dependence	0.00155	0.00672	CbGpPWpGaD
Vandetanib—FMO3—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00153	0.00663	CbGpPWpGaD
Vandetanib—EGFR—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00145	0.00631	CbGpPWpGaD
Vandetanib—ABCG2—brain—nicotine dependence	0.00139	0.00367	CbGeAlD
Vandetanib—FYN—VEGFA-VEGFR2 Pathway—WASF2—nicotine dependence	0.00137	0.00592	CbGpPWpGaD
Vandetanib—FYN—TCR Signaling Pathway—OPRM1—nicotine dependence	0.00135	0.00587	CbGpPWpGaD
Vandetanib—FYN—VEGFA-VEGFR2 Pathway—WASF1—nicotine dependence	0.00131	0.00568	CbGpPWpGaD
Vandetanib—FYN—Signaling by VEGF—WASF2—nicotine dependence	0.00129	0.00559	CbGpPWpGaD
Vandetanib—SRC—Fcgamma receptor (FCGR) dependent phagocytosis—WASF2—nicotine dependence	0.00126	0.00545	CbGpPWpGaD
Vandetanib—PDGFRB—PDGFR-beta signaling pathway—WASF2—nicotine dependence	0.00125	0.00542	CbGpPWpGaD
Vandetanib—FYN—Signaling by VEGF—WASF1—nicotine dependence	0.00124	0.00536	CbGpPWpGaD
Vandetanib—LYN—PDGFR-beta signaling pathway—WASF2—nicotine dependence	0.00122	0.00531	CbGpPWpGaD
Vandetanib—ABL1—PDGFR-beta signaling pathway—WASF2—nicotine dependence	0.00122	0.00529	CbGpPWpGaD
Vandetanib—FYN—PDGFR-beta signaling pathway—WASF2—nicotine dependence	0.00121	0.00523	CbGpPWpGaD
Vandetanib—SRC—Fcgamma receptor (FCGR) dependent phagocytosis—WASF1—nicotine dependence	0.00121	0.00523	CbGpPWpGaD
Vandetanib—VEGFA—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.0012	0.00521	CbGpPWpGaD
Vandetanib—EGFR—ErbB1 downstream signaling—WASF2—nicotine dependence	0.0012	0.00519	CbGpPWpGaD
Vandetanib—VEGFA—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00109	0.00473	CbGpPWpGaD
Vandetanib—PDGFRB—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00109	0.00471	CbGpPWpGaD
Vandetanib—PDGFRB—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00104	0.00452	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling by NGF—FGD1—nicotine dependence	0.00104	0.0045	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—TAS2R16—nicotine dependence	0.00103	0.00448	CbGpPWpGaD
Vandetanib—SRC—ErbB1 downstream signaling—WASF2—nicotine dependence	0.00102	0.00443	CbGpPWpGaD
Vandetanib—SRC—VEGFA-VEGFR2 Pathway—WASF2—nicotine dependence	0.00101	0.00436	CbGpPWpGaD
Vandetanib—LCK—PDGFR-beta signaling pathway—WASF2—nicotine dependence	0.001	0.00435	CbGpPWpGaD
Vandetanib—FYN—Signaling by NGF—FGD1—nicotine dependence	0.000999	0.00433	CbGpPWpGaD
Vandetanib—SRC—VEGFA-VEGFR2 Pathway—WASF1—nicotine dependence	0.000965	0.00418	CbGpPWpGaD
Vandetanib—SRC—Signaling by VEGF—WASF2—nicotine dependence	0.00095	0.00412	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—TAS2R16—nicotine dependence	0.000945	0.0041	CbGpPWpGaD
Vandetanib—SRC—Signaling by VEGF—WASF1—nicotine dependence	0.000911	0.00395	CbGpPWpGaD
Vandetanib—EGFR—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.000905	0.00392	CbGpPWpGaD
Vandetanib—SRC—PDGFR-beta signaling pathway—WASF2—nicotine dependence	0.000889	0.00385	CbGpPWpGaD
Vandetanib—EGFR—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.000868	0.00376	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—TAS2R16—nicotine dependence	0.000864	0.00375	CbGpPWpGaD
Vandetanib—EGFR—Signaling by NGF—FGD1—nicotine dependence	0.000863	0.00374	CbGpPWpGaD
Vandetanib—LCK—Signaling by NGF—FGD1—nicotine dependence	0.000832	0.00361	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—FGD1—nicotine dependence	0.000811	0.00352	CbGpPWpGaD
Vandetanib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000769	0.00333	CbGpPWpGaD
Vandetanib—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000759	0.00329	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—FGD1—nicotine dependence	0.000742	0.00322	CbGpPWpGaD
Vandetanib—SRC—Signaling by NGF—FGD1—nicotine dependence	0.000736	0.00319	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—AKR1B10—nicotine dependence	0.000716	0.00311	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—TAS2R16—nicotine dependence	0.000716	0.00311	CbGpPWpGaD
Vandetanib—MKNK1—Disease—AKR1B10—nicotine dependence	0.000709	0.00307	CbGpPWpGaD
Vandetanib—IRAK4—Innate Immune System—WASF2—nicotine dependence	0.00069	0.00299	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—FGD1—nicotine dependence	0.000678	0.00294	CbGpPWpGaD
Vandetanib—IRAK4—Innate Immune System—WASF1—nicotine dependence	0.000662	0.00287	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—AKR1B10—nicotine dependence	0.000655	0.00284	CbGpPWpGaD
Vandetanib—RIPK2—Innate Immune System—WASF2—nicotine dependence	0.000624	0.00271	CbGpPWpGaD
Vandetanib—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000623	0.0027	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—AKR1B10—nicotine dependence	0.000599	0.0026	CbGpPWpGaD
Vandetanib—FGR—Innate Immune System—WASF2—nicotine dependence	0.000598	0.0026	CbGpPWpGaD
Vandetanib—RIPK2—Innate Immune System—WASF1—nicotine dependence	0.000598	0.0026	CbGpPWpGaD
Vandetanib—FMO1—Metabolism—CYP2A7—nicotine dependence	0.000582	0.00252	CbGpPWpGaD
Vandetanib—FGR—Innate Immune System—WASF1—nicotine dependence	0.000574	0.00249	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—FGD1—nicotine dependence	0.000562	0.00244	CbGpPWpGaD
Vandetanib—ERBB3—Innate Immune System—WASF2—nicotine dependence	0.00055	0.00239	CbGpPWpGaD
Vandetanib—ERBB3—Innate Immune System—WASF1—nicotine dependence	0.000528	0.00229	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—WASF2—nicotine dependence	0.000505	0.00219	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—AKR1B10—nicotine dependence	0.000496	0.00215	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—WASF1—nicotine dependence	0.000484	0.0021	CbGpPWpGaD
Vandetanib—YES1—Innate Immune System—WASF2—nicotine dependence	0.000483	0.0021	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—TAS2R16—nicotine dependence	0.000481	0.00209	CbGpPWpGaD
Vandetanib—YES1—Innate Immune System—WASF1—nicotine dependence	0.000463	0.00201	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—WASF2—nicotine dependence	0.000461	0.002	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—WASF1—nicotine dependence	0.000442	0.00192	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—TAS2R16—nicotine dependence	0.00044	0.00191	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—OPRM1—nicotine dependence	0.000436	0.00189	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—TAS2R16—nicotine dependence	0.000429	0.00186	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—TAS2R16—nicotine dependence	0.000424	0.00184	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—WASF2—nicotine dependence	0.000422	0.00183	CbGpPWpGaD
Vandetanib—ERBB3—Disease—AKR1B10—nicotine dependence	0.00042	0.00182	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—CYP2A7—nicotine dependence	0.000416	0.00181	CbGpPWpGaD
Vandetanib—ABCC1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000412	0.00179	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—WASF1—nicotine dependence	0.000405	0.00176	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—WASF2—nicotine dependence	0.000402	0.00174	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—TAS2R16—nicotine dependence	0.0004	0.00173	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—OPRM1—nicotine dependence	0.000398	0.00173	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—TAS2R16—nicotine dependence	0.000386	0.00167	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—WASF1—nicotine dependence	0.000385	0.00167	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—FGD1—nicotine dependence	0.000378	0.00164	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—TAS2R16—nicotine dependence	0.000373	0.00162	CbGpPWpGaD
Vandetanib—PDGFRB—Innate Immune System—WASF2—nicotine dependence	0.000368	0.0016	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—OPRM1—nicotine dependence	0.000364	0.00158	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—WASF2—nicotine dependence	0.000364	0.00158	CbGpPWpGaD
Vandetanib—ABCG2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000363	0.00157	CbGpPWpGaD
Vandetanib—LYN—Innate Immune System—WASF2—nicotine dependence	0.00036	0.00156	CbGpPWpGaD
Vandetanib—ABL1—Innate Immune System—WASF2—nicotine dependence	0.000359	0.00155	CbGpPWpGaD
Vandetanib—FYN—Innate Immune System—WASF2—nicotine dependence	0.000355	0.00154	CbGpPWpGaD
Vandetanib—PDGFRB—Innate Immune System—WASF1—nicotine dependence	0.000353	0.00153	CbGpPWpGaD
Vandetanib—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000351	0.00152	CbGpPWpGaD
Vandetanib—BLK—Immune System—WASF2—nicotine dependence	0.00035	0.00152	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—WASF2—nicotine dependence	0.00035	0.00152	CbGpPWpGaD
Vandetanib—FGR—Immune System—WASF2—nicotine dependence	0.000349	0.00151	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—WASF1—nicotine dependence	0.000349	0.00151	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—FGD1—nicotine dependence	0.000345	0.0015	CbGpPWpGaD
Vandetanib—LYN—Innate Immune System—WASF1—nicotine dependence	0.000345	0.0015	CbGpPWpGaD
Vandetanib—ABL1—Innate Immune System—WASF1—nicotine dependence	0.000344	0.00149	CbGpPWpGaD
Vandetanib—FYN—Innate Immune System—WASF1—nicotine dependence	0.00034	0.00147	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—FGD1—nicotine dependence	0.000337	0.00146	CbGpPWpGaD
Vandetanib—BLK—Immune System—WASF1—nicotine dependence	0.000335	0.00145	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—WASF1—nicotine dependence	0.000335	0.00145	CbGpPWpGaD
Vandetanib—FGR—Immune System—WASF1—nicotine dependence	0.000334	0.00145	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—AKR1B10—nicotine dependence	0.000334	0.00145	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—FGD1—nicotine dependence	0.000333	0.00144	CbGpPWpGaD
Vandetanib—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000331	0.00144	CbGpPWpGaD
Vandetanib—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000327	0.00142	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—WASF2—nicotine dependence	0.000321	0.00139	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—DRD2—nicotine dependence	0.000315	0.00137	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—FGD1—nicotine dependence	0.000314	0.00136	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—WASF1—nicotine dependence	0.000307	0.00133	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—WASF2—nicotine dependence	0.000306	0.00133	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—AKR1B10—nicotine dependence	0.000305	0.00132	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—FGD1—nicotine dependence	0.000303	0.00131	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—OPRM1—nicotine dependence	0.000302	0.00131	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—AKR1B10—nicotine dependence	0.000297	0.00129	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—WASF2—nicotine dependence	0.000295	0.00128	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—AKR1B10—nicotine dependence	0.000294	0.00128	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—WASF1—nicotine dependence	0.000294	0.00127	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—FGD1—nicotine dependence	0.000292	0.00127	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—DRD2—nicotine dependence	0.000288	0.00125	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—TAS2R16—nicotine dependence	0.000284	0.00123	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—WASF1—nicotine dependence	0.000283	0.00123	CbGpPWpGaD
Vandetanib—YES1—Immune System—WASF2—nicotine dependence	0.000281	0.00122	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—AKR1B10—nicotine dependence	0.000281	0.00122	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—TAS2R16—nicotine dependence	0.000278	0.0012	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—TAS2R16—nicotine dependence	0.000273	0.00119	CbGpPWpGaD
Vandetanib—FYN—Disease—AKR1B10—nicotine dependence	0.000271	0.00117	CbGpPWpGaD
Vandetanib—YES1—Immune System—WASF1—nicotine dependence	0.00027	0.00117	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—AKR1B10—nicotine dependence	0.000267	0.00116	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—DRD2—nicotine dependence	0.000263	0.00114	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—WASF2—nicotine dependence	0.000261	0.00113	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—AKR1B10—nicotine dependence	0.000258	0.00112	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—WASF1—nicotine dependence	0.000251	0.00109	CbGpPWpGaD
Vandetanib—ABCC1—Disease—AKR1B10—nicotine dependence	0.000248	0.00108	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—TAS2R16—nicotine dependence	0.000236	0.00102	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—WASF2—nicotine dependence	0.000235	0.00102	CbGpPWpGaD
Vandetanib—EGFR—Disease—AKR1B10—nicotine dependence	0.000234	0.00101	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TAS2R16—nicotine dependence	0.000228	0.000987	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—WASF1—nicotine dependence	0.000225	0.000977	CbGpPWpGaD
Vandetanib—LCK—Disease—AKR1B10—nicotine dependence	0.000225	0.000977	CbGpPWpGaD
Vandetanib—ALB—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000224	0.000971	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—FGD1—nicotine dependence	0.000223	0.000965	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—DRD2—nicotine dependence	0.000218	0.000947	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—FGD1—nicotine dependence	0.000218	0.000945	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—WASF2—nicotine dependence	0.000215	0.000932	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—FGD1—nicotine dependence	0.000215	0.000931	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—WASF2—nicotine dependence	0.000214	0.000929	CbGpPWpGaD
Vandetanib—LYN—Immune System—WASF2—nicotine dependence	0.00021	0.00091	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—WASF2—nicotine dependence	0.00021	0.000909	CbGpPWpGaD
Vandetanib—ABL1—Immune System—WASF2—nicotine dependence	0.000209	0.000906	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—WASF2—nicotine dependence	0.000207	0.000899	CbGpPWpGaD
Vandetanib—FYN—Immune System—WASF2—nicotine dependence	0.000207	0.000896	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—WASF1—nicotine dependence	0.000206	0.000894	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—WASF1—nicotine dependence	0.000205	0.000891	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—OPRM1—nicotine dependence	0.000203	0.00088	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TAS2R16—nicotine dependence	0.000202	0.000874	CbGpPWpGaD
Vandetanib—LYN—Immune System—WASF1—nicotine dependence	0.000201	0.000872	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—WASF1—nicotine dependence	0.000201	0.000871	CbGpPWpGaD
Vandetanib—ABL1—Immune System—WASF1—nicotine dependence	0.0002	0.000868	CbGpPWpGaD
Vandetanib—SRC—Disease—AKR1B10—nicotine dependence	0.000199	0.000865	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—WASF1—nicotine dependence	0.000199	0.000862	CbGpPWpGaD
Vandetanib—FYN—Immune System—WASF1—nicotine dependence	0.000198	0.000859	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—AKR1B10—nicotine dependence	0.000197	0.000853	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—CYP2A7—nicotine dependence	0.000193	0.000838	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—AKR1B10—nicotine dependence	0.000193	0.000835	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—AKR1B10—nicotine dependence	0.00019	0.000822	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—WASF2—nicotine dependence	0.000188	0.000817	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—OPRM1—nicotine dependence	0.000186	0.000805	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—FGD1—nicotine dependence	0.000185	0.000804	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—WASF2—nicotine dependence	0.000182	0.000789	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—OPRM1—nicotine dependence	0.000181	0.000784	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—WASF1—nicotine dependence	0.000181	0.000783	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—OPRM1—nicotine dependence	0.000179	0.000776	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—FGD1—nicotine dependence	0.000179	0.000775	CbGpPWpGaD
Vandetanib—EGFR—Immune System—WASF2—nicotine dependence	0.000178	0.000774	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—WASF1—nicotine dependence	0.000174	0.000756	CbGpPWpGaD
Vandetanib—LCK—Immune System—WASF2—nicotine dependence	0.000172	0.000746	CbGpPWpGaD
Vandetanib—EGFR—Immune System—WASF1—nicotine dependence	0.000171	0.000742	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—CYP2A7—nicotine dependence	0.00017	0.000737	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—OPRM1—nicotine dependence	0.000169	0.000731	CbGpPWpGaD
Vandetanib—LCK—Immune System—WASF1—nicotine dependence	0.000165	0.000715	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—AKR1B10—nicotine dependence	0.000164	0.00071	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—OPRM1—nicotine dependence	0.000163	0.000705	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—FGD1—nicotine dependence	0.000158	0.000686	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—AKR1B10—nicotine dependence	0.000158	0.000684	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—OPRM1—nicotine dependence	0.000157	0.000681	CbGpPWpGaD
Vandetanib—SRC—Immune System—WASF2—nicotine dependence	0.000152	0.00066	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—DRD2—nicotine dependence	0.000147	0.000636	CbGpPWpGaD
Vandetanib—SRC—Immune System—WASF1—nicotine dependence	0.000146	0.000633	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—AKR1B10—nicotine dependence	0.00014	0.000606	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—WASF2—nicotine dependence	0.000139	0.000601	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—WASF2—nicotine dependence	0.000136	0.000588	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—DRD2—nicotine dependence	0.000134	0.000582	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—WASF2—nicotine dependence	0.000134	0.000579	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—WASF1—nicotine dependence	0.000133	0.000576	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—DRD2—nicotine dependence	0.000131	0.000567	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—WASF1—nicotine dependence	0.00013	0.000564	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—DRD2—nicotine dependence	0.000129	0.000561	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—WASF1—nicotine dependence	0.000128	0.000555	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—DRD2—nicotine dependence	0.000122	0.000529	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—OPRM1—nicotine dependence	0.00012	0.000519	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—DRD2—nicotine dependence	0.000118	0.00051	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—OPRM1—nicotine dependence	0.000117	0.000508	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—WASF2—nicotine dependence	0.000115	0.0005	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—OPRM1—nicotine dependence	0.000115	0.0005	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—DRD2—nicotine dependence	0.000114	0.000492	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—WASF2—nicotine dependence	0.000111	0.000482	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—WASF1—nicotine dependence	0.000111	0.00048	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—WASF1—nicotine dependence	0.000107	0.000462	CbGpPWpGaD
Vandetanib—ALB—Metabolism—CYP2A7—nicotine dependence	0.000105	0.000455	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—OPRM1—nicotine dependence	9.96e-05	0.000432	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—WASF2—nicotine dependence	9.84e-05	0.000427	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—OPRM1—nicotine dependence	9.6e-05	0.000416	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—WASF1—nicotine dependence	9.44e-05	0.000409	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—DRD2—nicotine dependence	8.65e-05	0.000375	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—OPRM1—nicotine dependence	8.5e-05	0.000368	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—DRD2—nicotine dependence	8.47e-05	0.000367	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—DRD2—nicotine dependence	8.33e-05	0.000361	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—DRD2—nicotine dependence	7.2e-05	0.000312	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—DRD2—nicotine dependence	6.94e-05	0.000301	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—DRD2—nicotine dependence	6.14e-05	0.000266	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CYP2A7—nicotine dependence	5.66e-05	0.000246	CbGpPWpGaD
